These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 22820853

  • 1. A meta-analysis of randomized controlled trials comparing tacrolimus with intravenous cyclophosphamide in the induction treatment for lupus nephritis.
    Deng J, Huo D, Wu Q, Yang Z, Liao Y.
    Tohoku J Exp Med; 2012 Aug; 227(4):281-8. PubMed ID: 22820853
    [Abstract] [Full Text] [Related]

  • 2. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
    Zhang X, Ji L, Yang L, Tang X, Qin W.
    Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720
    [Abstract] [Full Text] [Related]

  • 3. Multitarget therapy versus intravenous cyclophosphamide in the induction treatment of lupus nephritis: a metaanalysis of randomized controlled trials.
    Deng J, Luo L, Zhu L, Xie H, xie H.
    Turk J Med Sci; 2018 Oct 31; 48(5):901-910. PubMed ID: 30384552
    [Abstract] [Full Text] [Related]

  • 4. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Lupus; 2015 Dec 31; 24(14):1520-8. PubMed ID: 26162684
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
    Hannah J, Casian A, D'Cruz D.
    Autoimmun Rev; 2016 Jan 31; 15(1):93-101. PubMed ID: 26427983
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
    Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J.
    Lupus; 2012 Aug 31; 21(9):1025-35. PubMed ID: 22570338
    [Abstract] [Full Text] [Related]

  • 7. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
    Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM.
    Lupus; 2019 Apr 31; 28(5):613-620. PubMed ID: 30871425
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr 31; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
    Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F.
    Clin Exp Rheumatol; 2013 Apr 31; 31(1):62-8. PubMed ID: 22935463
    [Abstract] [Full Text] [Related]

  • 11. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M, Qi C, Zha Y, Chen J, Luo P, Wang L, Sun Z, Wan J, Xing C, Wang S, Jiang G, Sun M, Chen Q, Chen J, Li D, Guan T, Ni Z.
    Clin Rheumatol; 2019 Mar 31; 38(3):859-867. PubMed ID: 30426311
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Z Rheumatol; 2017 Dec 31; 76(10):904-912. PubMed ID: 27638015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z, Chen J, Lin H, Liu F, He Y, He Y, Miao L, Chen N, Li Y, Gu Y, Shi W, Hu W, Liu Z, Bao H, Zeng C, Zhou M.
    Ann Intern Med; 2015 Jan 06; 162(1):18-26. PubMed ID: 25383558
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial.
    Zheng Z, Zhang H, Peng X, Zhang C, Xing C, Xu G, Fu P, Ni Z, Chen J, Xu Z, Zhao MH, Li S, Huang X, Miao L, Chen X, Liu B, He Y, Li J, Liu L, Kadeerbai H, Liu Z, Liu Z.
    JAMA Netw Open; 2022 Mar 01; 5(3):e224492. PubMed ID: 35353167
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul 01; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.
    Kamanamool N, McEvoy M, Attia J, Ingsathit A, Ngamjanyaporn P, Thakkinstian A.
    Medicine (Baltimore); 2010 Jul 01; 89(4):227-235. PubMed ID: 20616662
    [Abstract] [Full Text] [Related]

  • 19. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Henderson LK, Masson P, Craig JC, Roberts MA, Flanc RS, Strippoli GF, Webster AC.
    Am J Kidney Dis; 2013 Jan 01; 61(1):74-87. PubMed ID: 23182601
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a meta-analysis.
    Lee YH, Song GG.
    Z Rheumatol; 2023 Nov 01; 82(9):754-762. PubMed ID: 36607421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.